FC-BINDUNGSFRAGMENTE MIT EINER PD-L1 ANTIGEN-BINDUNGSSTELLE
European patent · EP3728316 · In force
Register entry
- Publication number
- EP3728316
- Application number
- EP18833200
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Dec 19, 2018
- Published
- Oct 28, 2020
- Granted
- Feb 26, 2025
- Protection ends at the latest
- Dec 18, 2038
- Next annual fee due
- Dec 31, 2026
- IPC classes
- C07K 16/28 (2006.01)
- Priority
- US 201762607686 P 19.12.2017US 201862657195 P 13.04.2018
- PCT application
- PCT/EP2018/085834 19.12.2018
- PCT publication
- WO2019/121906 27.06.2019
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jan 7, 2026
Change
Published in Swissreg on 07.01.2026
- Jan 1, 2026
Change
Published in Swissreg on 01.01.2026
- May 21, 2025
Agent entered
- Representative
- Dennemeyer AG, Bahnhofstrasse 23, 6300 Zug
Published in Swissreg on 21.05.2025
- May 14, 2025
Owner
- Owner
- invoX Pharma Limited, Suite 2, First Floor, The Westworks, 195 Wood Lane, White City Place, London W12 7FQ, United Kingdom → F-star Therapeutics Limited, Eddeva B920, Babraham Research Campus, Cambridge, CB22 3AT, United Kingdom
Published in Swissreg on 14.05.2025
- Feb 26, 2025
Granted
- Specification status
- Non-published patent application → Granted patent
- Status of protective title
- Initiated → Active
Published in Swissreg on 26.02.2025
Parties
Inventor
Cambridge, Cambridgeshire CB22 3AT, GB
Cambridge, Cambridgeshire CB22 3AT, GB
Cambridge, Cambridgeshire CB22 3AT, GB
Cambridge, Cambridgeshire CB22 3AT, GB
Cambridge, Cambridgeshire CB22 3AT, GB
Cambridge, Cambridgeshire CB22 3AT, GB
Cambridge, Cambridgeshire CB22 3AT, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.